At Risk Studies
Study Name Principal Investigator Natural History Study “Pathway to Prevention” Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22) Desmond Schatz, M.D. CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Desmond Schatz, M.D.